The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
NCT05990712 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2023-08-14
Summary
This study assesses the impact of two differing ocular hygiene regimens prior to cataract surgery. The first regimen includes an omega-3 supplement and the second without, and both include an at-home lid wipe and cleansing eye drops. These regimens will be assessed on microbial load, inflammation, tear osmolarity, and dry eye metrics. Patients will be randomized to either the omega-3 group + 3-part hygiene regimen, or the group with only the 3-part hygiene regimen. Data will be collected for inflammation through a test (InflammaDry) that measures an inflammatory marker, dry eye metrics via an imaging tool called Oculus 5M and the Canadian Dry Eye Assessment (CDEA) questionnaire, tear osmolarity through Tear Labs device, and area of growth for conjunctiva microbial load by swabbing the conjunctiva of the eye. Dry eye metrics (CDEA and Oculus 5M) will be collected during the patient's baseline appointment, 2-5 days prior to surgery, and post-operative month 1. Microbial load swabs will be collected at baseline, 2-5 days prior to surgery, and date of the surgery. An ocular assessment will also be completed at baseline, one week post-operation, and one month post-operation. All metrics will be compared to the fellow eye. The usage of omega-3 will be compared to the regimen without omega-3.
Conditions
- Dry Eye
- Dry Eye Syndromes
- Cataract
Interventions
- DIETARY_SUPPLEMENT
-
Omega-3
Omega-3 is a fatty acid and there is evidence that the consumption of re-esterified oral omega-3 supplements over the course of 6 to 8 weeks aid in reducing inflammation, dry eye, and optimizing tear osmolarity. The oral omega-3 supplement taken daily.
- DRUG
-
Trehalose
Eyedrops consisting of trehalose and sodium hyaluronate that lubricate and hydrate the eye to relieve dry eye.
- DRUG
-
Zocular Eyelid System Treatment
A lid cleaning and debridement system that consists of okra-based gel to relieve dry eye or inflammation. The gel is applied to the eyelid margin and lashes with a cotton swab.
- OTHER
-
Blephadex cleansing eyelid wipes
Eyelid cleansing wipes with tea tree oil and coconut that help reduce infection.
Sponsors & Collaborators
-
WIlliam Osler Health Systems
collaborator UNKNOWN -
Forsee Canada
collaborator UNKNOWN -
Uptown Eye Specialists
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-01-01
- Completion
- 2024-01-01
- FDA Drug
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
No Drop Post-Op Cataract Surgery
NCT03864133 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
NCT06681688 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Lubricating Eye Drops After Routine Cataract Surgery
NCT04465071 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
NCT04810962 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
NCT00170729 ·Status: COMPLETED ·Phase: PHASE4
-
Hypochlorous Acid Disinfection Prior to Cataract Surgery
NCT04568213 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
NCT04739709 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen
NCT03578276 ·Status: COMPLETED ·Phase: PHASE4
-
Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery
NCT05905237 ·Status: COMPLETED
-
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery
NCT00645671 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
NCT00333918 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients
NCT01859702 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
NCT01395069 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
NCT01060072 ·Status: COMPLETED ·Phase: PHASE3
-
Dropless vs. Standard Drops Contralateral Eye Study
NCT02515045 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
NCT00824070 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
NCT01193127 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain
NCT02793817 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Variables in Cataract Surgery
NCT00407017 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Optimizing Anti-inflammatory Prophylaxis
NCT03383328 ·Status: COMPLETED ·Phase: PHASE4
-
Anesthetic and Dilating Gel for Cataract Surgery
NCT00335400 ·Status: COMPLETED ·Phase: NA
-
Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.
NCT03640650 ·Status: TERMINATED ·Phase: PHASE4
-
Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery
NCT00335231 ·Status: WITHDRAWN ·Phase: NA